Work

Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab

Year: 2013
Type: article
Study design: Case Report
Abstract: Although controlled clinical trials will be required to establish the effectiveness of ustekinumab in AD, we suggest that ustekinumab might be a useful and safe treatment of refractory AD in young patients.
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2043082699
FWCI: 7.009
Cites: 5
Cited by: 44
Related to: 10